Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39174
Title: | Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract | Authors: | Liu, Kang Zhao, Hongda Alvarez-Maestro, Mario Gravas, Stavros VAN RENTERGHEM, Koenraad Zeng, Guohua Ng, Chi-Fai Laguna, Pilar Teoh, Jeremy Yuen-Chun De La Rosette, Jean |
Issue Date: | 2022 | Publisher: | MDPI | Source: | Current Oncology, 29 (12) , p. 9284 -9293 | Abstract: | Objective: To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor. Design, Setting, and Participants: The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of the Upper Tract (CROES-UTUC) Registry included 1134 UTUC patients with or without concurrent bladder tumor treated between 2014 and 2019. Results: In 218 (19.2%) cases, concurrent bladder tumor was present, while in 916 (80.8%) patients, no bladder cancer was found. In the multivariable Cox regression analysis, concomitant bladder tumor (hazard ratio (HR) 1.562, 95% confidence interval (CI) 0.954-2.560, p = 0.076) indicated a trend associated with recurrence-free survival for UTUC. Further data dissection confirmed that concomitant bladder tumor is a risk factor of bladder recurrence (HR 1.874, 95% CI 1.104-3.183, p = 0.020) but not UTUC recurrence (HR 0.876, 95% CI 0.292-2.625, p = 0.812). Kidney-sparing surgery (KSS) (HR 3.940, 95% CI 1.352-11.486, p = 0.012), pathological T staging >= pT2 (HR 2.840, 95% 1.039-7.763, p = 0.042) were significantly associated with UTUC recurrence. KSS does not affect bladder recurrence (HR 0.619, 95% CI 0.242-1.580, p = 0.315). A limitation is the retrospective nature of the present study analysis. Conclusions: The presence of concomitant bladder tumor does not increase risk of UTUC recurrence, but it results in an increased risk of bladder recurrence. KSS does not affect bladder recurrence and can still be considered in patients with concomitant bladder tumor. | Notes: | Teoh, JYC (corresponding author), Chinese Univ Hong Kong, SH Ho Urol Ctr, Dept Surg, Hong Kong 999077, Peoples R China. jeremyteoh@surgery.cuhk.edu.hk |
Keywords: | concomitant bladder tumor;upper tract urothelial carcinoma;kidney-sparing surgery;recurrence-free survival | Document URI: | http://hdl.handle.net/1942/39174 | ISSN: | 1198-0052 | e-ISSN: | 1718-7729 | DOI: | 10.3390/curroncol29120727 | ISI #: | 000900604800001 | Rights: | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract.pdf | Published version | 1.03 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.